Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia
- 1 March 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 288 (3) , E625-E632
- https://doi.org/10.1152/ajpendo.00184.2004
Abstract
Resistin is an adipocyte-secreted hormone proposed to link obesity with insulin resistance and diabetes, but no previous study has performed a joint quantitative evaluation of white adipose tissue (WAT) resistin mRNA expression and serum levels in relation to insulinemia and glycemia in mice. We have thus comparatively assessed WAT resistin mRNA expression and serum resistin levels in lean C57BL/6J mice and various mouse models of obesity, including diet-induced obese (DIO) C57BL/6J mice, high fat-fed TNF-α−/− mice, and brown adipose tissue (BAT)-deficient uncoupling protein-diphtheria toxin A chain (UCP1-DTA) mice. We also studied whether treatment with the weight-reducing and insulin-sensitizing compounds, MTII, an α-melanocyte-stimulating hormone analog, or CNTFAx15, a ciliary neurotrophic factor analog, alters resistin mRNA expression and/or circulating levels in lean and DIO C57BL/6J mice. We find that resistin mRNA expression is similar in DIO and lean C57BL/6J mice, as well as in TNF-α−/− and wild-type (WT) mice. Circulating resistin levels, however, are higher in DIO C57BL/6J, high fat-fed TNF-α−/−, and UCP1-DTA mice compared with lean controls. Moreover, although resistin mRNA expression is upregulated by MTII treatment for 24 h and downregulated by CNTFAx15 treatment for 3 or 7 days, circulating resistin levels are not altered by MTII or CNTFAx15 treatment. In addition, serum resistin levels, but not resistin mRNA expression levels, are correlated with body weight, and neither resistin mRNA expression nor serum resistin levels are correlated with serum insulin or glucose levels. We conclude that transcriptional regulation of resistin in WAT does not correlate with circulating resistin levels and that circulating resistin is unlikely to play a major endocrine role in insulin resistance or glycemia in mice.Keywords
This publication has 49 references indexed in Scilit:
- Resistin is expressed in human macrophages and directly regulated by PPARγ activatorsBiochemical and Biophysical Research Communications, 2003
- Expression of resistin in the adipose tissue is modulatedby various factors including peroxisome proliferator-activated receptor alphaDiabetes, Obesity and Metabolism, 2002
- Decreased Resistin Expression in Mice with Different Sensitivities to a High-Fat DietBiochemical and Biophysical Research Communications, 2001
- Tumor Necrosis Factor α Is a Negative Regulator of Resistin Gene Expression and Secretion in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2001
- Differential Regulation of Adipocytokine mRNAs by Rosiglitazone in db/db MiceBiochemical and Biophysical Research Communications, 2001
- Adipose Tissue Resistin Expression Is Severely Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor γ AgonistsJournal of Biological Chemistry, 2001
- Insulin Resistance and Type 2 Diabetes Are Not Related to Resistin Expression in Human Fat Cells or Skeletal MuscleBiochemical and Biophysical Research Communications, 2001
- A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte DifferentiationJournal of Biological Chemistry, 2001
- FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000
- Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemiaEndocrinology, 1996